122 related articles for article (PubMed ID: 1362612)
1. [Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments].
Ménard J; Chatellier G
Presse Med; 1992 Nov; 21(37):1762-7. PubMed ID: 1362612
[TBL] [Abstract][Full Text] [Related]
2. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
[TBL] [Abstract][Full Text] [Related]
3. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
Petrovitch H; Vogt TM; Berge KG
Geriatrics; 1992 Mar; 47(3):30-2, 35-8. PubMed ID: 1544585
[TBL] [Abstract][Full Text] [Related]
4. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
[TBL] [Abstract][Full Text] [Related]
5. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
JAMA; 1991 Jun; 265(24):3255-64. PubMed ID: 2046107
[TBL] [Abstract][Full Text] [Related]
6. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group.
Hypertension; 1993 Mar; 21(3):335-43. PubMed ID: 8478043
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
Franse LV; Pahor M; Di Bari M; Shorr RI; Wan JY; Somes GW; Applegate WB
J Hypertens; 2000 Aug; 18(8):1149-54. PubMed ID: 10954008
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
[TBL] [Abstract][Full Text] [Related]
9. Stroke in the elderly treated for systolic hypertension (SHEP).
Singer RB
J Insur Med; 1991; 23(4):265-9. PubMed ID: 10148513
[No Abstract] [Full Text] [Related]
10. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
[TBL] [Abstract][Full Text] [Related]
11. [Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle].
Chieppa S; Lobascio C; Brandini V; Iarussi D; Giuliani F; Langella S; De Simone R
Cardiologia; 1989 Aug; 34(8):695-9. PubMed ID: 2605580
[TBL] [Abstract][Full Text] [Related]
12. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
13. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.
Probstfield JL; Applegate WB; Borhani NO; Curb JD; Cutler JA; Davis BR; Furberg CD; Hawkins CM; Lakatos E; Page LB
Clin Exp Hypertens A; 1989; 11(5-6):973-89. PubMed ID: 2676266
[TBL] [Abstract][Full Text] [Related]
14. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
15. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
17. Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events.
Furberg CD; Cutler JA
Hypertension; 1989 May; 13(5 Suppl):I57-61. PubMed ID: 2577460
[TBL] [Abstract][Full Text] [Related]
18. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
BMJ; 1992 Feb; 304(6824):405-12. PubMed ID: 1445513
[TBL] [Abstract][Full Text] [Related]
19. Future goals for the treatment of hypertension in the elderly with reference to STOP-Hypertension, SHEP, and the MRC trial in older adults.
Hansson L
Am J Hypertens; 1993 Mar; 6(3 Pt 2):40S-43S. PubMed ID: 8096706
[TBL] [Abstract][Full Text] [Related]
20. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
Hypertension; 2003 Sep; 42(3):239-46. PubMed ID: 12925554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
